An Essential Role for Coagulase in Staphylococcus aureus Biofilm Development Reveals New Therapeutic Possibilities for Device-Related Infections

J Infect Dis. 2015 Dec 15;212(12):1883-93. doi: 10.1093/infdis/jiv319. Epub 2015 Jun 4.

Abstract

High-level resistance to antimicrobial drugs is a major factor in the pathogenesis of chronic Staphylococcus aureus biofilm-associated, medical device-related infections. Antimicrobial susceptibility analysis revealed that biofilms grown for ≤ 24 hours on biomaterials conditioned with human plasma under venous shear in iron-free cell culture medium were significantly more susceptible to antistaphylococcal antibiotics. Biofilms formed under these physiologically relevant conditions were regulated by SaeRS and dependent on coagulase-catalyzed conversion of fibrinogen into fibrin. In contrast, SarA-regulated biofilms formed on uncoated polystyrene in nutrient-rich bacteriological medium were mediated by the previously characterized biofilm factors poly-N-acetyl glucosamine, fibronectin-binding proteins, or autolytic activity and were antibiotic resistant. Coagulase-mediated biofilms exhibited increased antimicrobial resistance over time (>48 hours) but were always susceptible to dispersal by the fibrinolytic enzymes plasmin or nattokinase. Biofilms recovered from infected central venous catheters in a rat model of device-related infection were dispersed by nattokinase, supporting the important role of the biofilm phenotype and identifying a potentially new therapeutic approach with antimicrobials and fibrinolytic drugs, particularly during the early stages of device-related infection.

Keywords: Staphylococcus; antimicrobial; biofilm; coagulase; infection; susceptibility.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Animals
  • Anti-Bacterial Agents / metabolism
  • Biofilms / drug effects*
  • Biofilms / growth & development*
  • Catheter-Related Infections / microbiology*
  • Catheter-Related Infections / prevention & control
  • Coagulase / metabolism*
  • Disease Models, Animal
  • Fibrinolytic Agents / metabolism*
  • Humans
  • Rats, Sprague-Dawley
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / enzymology*
  • Staphylococcus aureus / physiology*

Substances

  • Anti-Bacterial Agents
  • Coagulase
  • Fibrinolytic Agents